A comparative clinical study of Rasnasaptak Kashaya Ghanvati and Rasnapanchak Kashaya Ghanvati in Rheumatoid Arthritis

Phase 2/3

Not yet recruiting

• Conditions: Acquired deformity of musculoskeletal system, unspecified. Ayurveda Condition: AMAVATAH,

• Registration Number: CTRI/2023/08/056521
• Lead Sponsor: Government Ayurvedic College Patiala

Brief Summary

In this trial we are selecting patients of Amavata in two groups, in which we will do intervention study of study with Rasnasaptak kashaya ghanvati and Rasnapanchak kashaya ghanvati with the dose of two tablets of 500 mg BD assesment will be done on the subjective and objective parameters for the Amavata.

Route of Drug Adminitration - Oral

Follow up- Day 10, day 20, day 30

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-08-14
• Study Start: 2023-08-26

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patient willing for trial 2.
• Either Sex will be selected 3.
• Newly Diagnosed case and patient not on any medication since one month will be selected 4.
• Patient having classical symptoms of Rheumatoid Arthritis will be Selected.

Exclusion Criteria

• Age more than 70 yrs and less than 20 yrs.
• Patient not willing for trial.
• Pregnancy and lactating mothers 4.
• Patients suffering from any known case of severe systemic disorder like Crohn Disease, SLE, Graves disease, AIDS etc, which may interfere with the course of treatment will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Subjective Parameter- Grading will be done with sign & symptoms of Amavata	After one month intervention of Rasnasaptak kashaya Ghanvati and Rasnapanchak kashaya Ghanvati orally.
RA factor,ESR,CRP,SGOT,SGPT,Uric Acid,HB,TLC to rule out other pathologies	After one month intervention of Rasnasaptak kashaya Ghanvati and Rasnapanchak kashaya Ghanvati orally.

Secondary Outcome Measures

Name	Time	Method
Subjective parameter-grading will be done with sign & symptoms of Amavata RA factor, ESR,CRP,SGOT,SGPT,Uric acid,HB	After one mmonth intervention of Rasnasaptak Kashaya Ghanvati & Rasnapanchak Kashaya Ghanvati

Trial Locations

Locations (1)

Government Ayurvedic Hospital, Patiala; 🇮🇳 Patiala, PUNJAB, India

Government Ayurvedic Hospital, Patiala

🇮🇳Patiala, PUNJAB, India

Dr Komal Sharma

Principal investigator

9888672102

komalbatish97@gmail.com